Y-mAbs Therapeutics soars 163% in past year, outperforming 98% of the market

Media coverage

• Title	Y-mAbs Therapeutics soars 163% in past year, outperforming 98% of the market
  Media name/outlet	Global Round Up - Bullish & Bearish Signals
  Country/Territory	United States
  Date	9/3/24
  Persons	Navdeep Gill

• Title	Monthly: Y-mAbs Therapeutics (YMAB: $14.31) rises 17% on high volatility in August 2024
  Media name/outlet	Global Round Up - Bullish & Bearish Signals
  Country/Territory	United States
  Date	9/3/24
  Persons	Navdeep Gill